# Amylyx Pharmaceuticals, Inc.: Form SC 13D/A, filed Oct 4, 2023

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: SC 13D/A
- Filed: 2023-10-04
- Accepted by EDGAR: Oct 4, 2023, 16:19 ET
- Period: not reported
- Accession: 0001193125-23-250741
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000119312523250741/d426014dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000119312523250741/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000119312523250741/d426014dsc13da.htm

Filed Oct 4, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-250741. Last ingested by Listed: Nov 13, 2026, 14:43 ET. No prices; not investment advice.